Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.64 USD | -0.38% | -1.12% | +5.60% |
06-03 | Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial | CI |
05-30 | Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.60% | 35.42M | |
+18.30% | 3.43B | |
+2.40% | 2.27B | |
-19.52% | 2.03B | |
-21.26% | 1.63B | |
+31.30% | 1.16B | |
+18.08% | 714M | |
-9.39% | 703M | |
-22.55% | 500M | |
-1.29% | 279M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte's Chief Executive Ronnie Andrews Steps Down